Multi-hormonal weight loss combinations in diet-induced obese rats: Therapeutic potential of cholecystokinin?
- 11 May 2010
- journal article
- Published by Elsevier BV in Physiology & Behavior
- Vol. 100 (2), 187-195
- https://doi.org/10.1016/j.physbeh.2010.02.023
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A cholecystokinin‐1 receptor agonist (CCK‐8) mediates increased permeability of brain barriers to leptinBritish Journal of Pharmacology, 2008
- Antiobesity effects of the β-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese ratsInternational Journal of Obesity, 2008
- Measurement of Immediate‐Early Gene Activation‐ c‐fos and BeyondJournal of Neuroendocrinology, 2008
- Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studiesProceedings of the National Academy of Sciences of the United States of America, 2008
- The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axisAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Attenuation of the anorectic effects of glucagon, cholecystokinin, and bombesin by the amylin receptor antagonist CGRP(8–37)Peptides, 1996
- Subdiaphragmatic vagotomy does not influence the anorectic effect of amylinPeptides, 1995
- Endogenous Cholecystokinin Reduces Feeding in Young RatsScience, 1990
- Rapid development of tolerance to the behavioural actions of cholecystokininNature, 1983
- Cholecystokinin decreases food intake in rats.Journal of Comparative and Physiological Psychology, 1973